Daratumumab for Patients With Light Chain Amyloidosis

Clinical trial NCT06376214 · RECRUITING

Trial details

NCT number: NCT06376214
Sponsor: Nanjing University School of Medicine
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Light Chain (AL) Amyloidosis

Start date: 2023-01-01
Primary completion: 2025-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.